MPWT
XPH icon

MassMutual Private Wealth & Trust’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$3.66K – 1010
2018
Q4 		$3.66K Hold
100
– – ﹤0.01% 721
2018
Q3 		$4.86K Buy
+100
New +$4.74K ﹤0.01% 723

Other funds holding XPH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

MassMutual Private Wealth & Trust's XPH Position: Q1 2019 in Review

MassMutual Private Wealth & Trust sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2019, closing a stake of 100 shares — an estimated $3.66K sold.

MassMutual Private Wealth & Trust first reported a position in XPH in Q3 2018 and held it in 2 quarters. The position peaked at $4.86K in Q3 2018. 80 funds tracked by Wall St. Rank hold XPH as of Q1 2019.

  • MassMutual Private Wealth & Trust reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 100 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2019, an estimated $3.66K.
  • MassMutual Private Wealth & Trust first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's State Street SPDR S&P Pharmaceuticals ETF position peaked at $4.86K in Q3 2018.
  • 80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2019.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2019, filed 15 May 2019.